Contents

Current Pharmaceutical Design, Volume 15 - Number 30

Editorial [Hot topic: Phosphodiesterase-5 Inhibitors and their Use in the Treatment of Urological Conditions (Executive Editor: Perimenis Petros)]

, 15(30): 3463

Perimenis Petros


DOI: 10.2174/138161209789207033




PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

, 15(30): 3464 - 3475

D. Kouvelas, A. Goulas, G. Papazisis, C. Sardeli and C. Pourzitaki


DOI: 10.2174/138161209789206971




Phosphodiesterase Type 5 Inhibitors: Unmet Needs

, 15(30): 3476 - 3485

K. Hatzimouratidis and D. G. Hatzichristou


DOI: 10.2174/138161209789207042




Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment

, 15(30): 3486 - 3495

T. F. Al-Shaiji and G. B. Brock


DOI: 10.2174/138161209789206944




Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors

, 15(30): 3496 - 3501

F. Deho, A. Gallina, A. Salonia, A. Briganti, N. Suardi, G. Zanni, G. Guazzoni, P. Rigatti and F. Montorsi


DOI: 10.2174/138161209789206999




PDE5 Inhibitors in the Treatment of LUTS

, 15(30): 3502 - 3505

M. J. Speakman


DOI: 10.2174/138161209789207051




Is There a Role for PDE5 Inhibitors in the Management of Male Infertility Due to Defects in Testicular or Epididymal Function?

, 15(30): 3506 - 3520

F. Dimitriadis, P. Tsounapi, M. Saito, T. Watanabe, A. Sylakos, S. Tsabalas, I. Miyagawa and N. Sofikitis


DOI: 10.2174/138161209789207015




PDE5 Inhibitors in Non-Urological Conditions

, 15(30): 3521 - 3539

C. Vlachopoulos, D. Terentes-Printzios, N. Ioakeimidis, K. Rokkas and C. Stefanadis


DOI: 10.2174/138161209789206980




Phosphodiesterase-5 Inhibitors: Future Perspectives

, 15(30): 3540 - 3551

Giannitsas Konstantinos and Perimenis Petros


DOI: 10.2174/138161209789206953




Recent Advances of Fluorescent Technologies for Drug Discovery and Development

, 15(30): 3552 - 3570

Chiranjib Chakraborty, Chi-Hsin Hsu, Zhi-Hong Wen and Chan-Shing Lin


DOI: 10.2174/138161209789207006




Role of Calcitonin Gene-Related Peptide in Gastric Mucosal Defence and Healing

, 15(30): 3571 - 3576

S. Evangelista


DOI: 10.2174/138161209789207024




Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides

, 15(30): 3577 - 3589

D. Leali, P. Alessi, D. Coltrini, M. Rusnati, L. Zetta and M. Presta


DOI: 10.2174/138161209789206962




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science